<http://www.reactome.org/biopax/48892Evidence692> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.biopax.org/release/biopax-level3.owl#Evidence> .
<http://www.reactome.org/biopax/48892Evidence692> <http://www.biopax.org/release/biopax-level3.owl#comment> "Prior to mitogen activation, the inhibitory proteins, INK4 (p15, p16, p18, and p19) associate with the catalytic domain of free CDK4/6, preventing its association with cyclin, and thus its activation."^^<http://www.w3.org/2001/XMLSchema#string> .
<http://www.reactome.org/biopax/48892Evidence692> <http://www.biopax.org/release/biopax-level3.owl#xref> <http://identifiers.org/pubmed/8001816> .
<http://www.reactome.org/biopax/48892Evidence692> <http://www.biopax.org/release/biopax-level3.owl#xref> <http://identifiers.org/pubmed/8259215> .
<http://www.reactome.org/biopax/48892Evidence692> <http://www.biopax.org/release/biopax-level3.owl#xref> <http://identifiers.org/pubmed/8078588> .
<http://www.reactome.org/biopax/48892Evidence692> <http://www.biopax.org/release/biopax-level3.owl#xref> <http://identifiers.org/pubmed/8741839> .
<http://www.reactome.org/biopax/48892Evidence692> <http://www.biopax.org/release/biopax-level3.owl#evidenceCode> <http://www.reactome.org/biopax/48892EvidenceCodeVocabulary1> .